Mednet Logo
HomeCardiology
Cardiology

Cardiology

Expert discussions on heart failure, arrhythmias, interventional procedures, and cardiovascular risk management.

Recent Discussions

How do you decide between atorvastatin versus rosuvastatin and their high-intensity doses for statin-naive patients following a STEMI and PCI?

1
3 Answers

Mednet Member
Mednet Member
Cardiology · The George Washington University Hospital

20 mg of Crestor is highly effective and tolerable.

What is/are your preferred technique(s) for obtaining LV-Ao pressure gradients in the cath lab?

2 Answers

Mednet Member
Mednet Member
Cardiology · Kaiser Permanente Roseville Medical Center

Two other ways to do this I learned while the Langston Cather was on back order to use a 6F 75 or 85 cm R2P sheath parked in the ascending aorta and a 4F pigtail in the LV. With two transducers (on off the side of R2P and one on pigtail) and a 2F difference in size of catheters, you get nice fidelit...

Do you prefer using unfractionated heparin or low molecular weight heparin in stable patients presenting with NSTE ACS awaiting primary PCI (assuming normal renal function)?

1
2 Answers

Mednet Member
Mednet Member
Hospital Medicine · Yale School of Medicine/Yale-New Haven Hospital

I advocate for the use of LMWH. I see a surprising number of patients on unfractionated heparin with PTTs indicating either homeopathic (<35s) or supratherapeutic (>120s) levels of anticoagulation. The 2025 ACC/AHA Guideline for the Management of Patients With Acute Coronary Syndromes summarizes cli...

What should the LDL target be in patients with prediabetes and high lipoprotein (a) with family history of coronary artery disease?

1
7 Answers

Mednet Member
Mednet Member
Endocrinology · UCSF - Fresno

I don’t think that using Lp(a) to guide treatment is quite ready for prime time yet. It’s an independent predictor of risk compared to the rest of the lipid panel, but as far as I am aware, we do not yet have data that treating people based on it makes a difference. What I may do in this scenario is...

Where does dronedarone fall in your list of antiarrhythmics drugs to use in terms of efficacy and patient selection in contemporary management of atrial fibrillation?

2 Answers

Mednet Member
Mednet Member
Cardiology · Baylor Scott And White Cardiology Consultants Of Texas

Dronedarone tends to be my last choice for treatment of AF to maintain sinus rhythm of all currently available oral antiarrhythmic meds available in the US - least effective and very expensive drug. I may use it in patients that I believe would be better served with catheter ablation- treatment with...

What are some TTE findings that suggest worsening function of a bioprosthetic AVR that would require further surveillance or diagnostic imaging?

1 Answers

Mednet Member
Mednet Member
Cardiology · University of Texas Health Science Center at Houston

Doppler findings of an increasing transaortic gradient; 2D findings of decreased valve excursion and increased cusp calcification.

Do you discontinue amlodipine or use an alternative approach to manage peripheral edema when it occurs as a side effect of the medication?

4
7 Answers

Mednet Member
Mednet Member
Nephrology · UAB Medicine

Peripheral edema is a common complaint and can be exacerbated by any vasodilator therapy, including hydralazine and minoxidil. My initial approach to swelling is to 1) make sure there is no proteinuria, which can be easily overlooked in a diabetic who infrequently sees doctors; 2) assess heart and l...

What types of cardiac conduction abnormalities would lead you to avoid using tricyclic antidepressants?

6
8 Answers

Mednet Member
Mednet Member
Psychiatry · CDCR

I wouldn’t say it is a definite contraindication. But, I would want to be sure it is a longstanding patient and they are seeing a cardiologist regularly. Then, if the QTc were within reason, I would consider it; but it wouldn’t be high on my list of options.

What is your approach to checking preoperative cardiac biomarkers such as troponin and BNP?

2 Answers

Mednet Member
Mednet Member
Hospital Medicine · University of California, San Francisco

While now recommended as a means of risk stratification for those over 65 years with cardiac risk factors across all three guidelines (AHA/ACC, CCS, ESC), we mostly reserve the use of biomarkers preoperatively for patients in whom we are on the fence for obtaining additional cardiac workup. We view ...

How do you use NT-proBNP in patients with chronic kidney disease or end-stage kidney disease, given that these conditions can affect NT-proBNP levels?

3
1 Answers

Mednet Member
Mednet Member
Cardiology · NYU Langone Health

NT-proBNP is most useful for (a) diagnostic uncertainty in patients who present with dyspnea, and (b) prognostication in heart failure. It is released as a result of ventricular wall stress. In CKD, the clearance of NT-proBNP is impaired, leading to elevated levels. In late-stage CKD and ESRD, volum...